MBody AI Ltd. (MBAI) vs Mustang Bio, Inc. (MBIO)
A side-by-side comparison of MBody AI Ltd. and Mustang Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MBAI
MBody AI Ltd.
$3.20HealthcareDelayed quote: Oct 6, 2026, 11:42 AM EDT
MBIO
Mustang Bio, Inc.
$0.46HealthcareDelayed quote: Oct 6, 2026, 11:23 AM EDT
Total return — MBAI vs MBIO
growth of $100 · dividends reinvested · last 1yMBAI -67.4% (-67.4%/yr)MBIO -66.9% (-66.9%/yr)MBIO compounded faster over this window
MBAI MBIO
MBAI vs MBIO: by the numbers
- •MBIO is the larger company ($3M vs $3M market cap).
Metrics side by side
Valuation
| Metric | MBAI | MBIO |
|---|---|---|
| P/B ratio | 0.93 | 0.46 |
Profitability
| Metric | MBAI | MBIO |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | 120.45% | -40.20% |
| ROIC | -69.04% | -45.77% |
Growth (annualized)
| Metric | MBAI | MBIO |
|---|---|---|
| Total return CAGR (5Y) | N/A | -80.80% |
Go deeper
Dig into the metrics
MBody AI ROEMustang Bio ROEMBody AI operating marginMustang Bio operating marginMBody AI revenue growthMustang Bio revenue growthMBody AI free cash flowMustang Bio free cash flow
MBody AI & Mustang Bio appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.